Mrna COVID-19 vaccine

1. Mrna COVID-19 vaccine improves immune response in humans.

   “mRNA COVID-19 vaccines generated strong immune responses in older adults, though lower than in younger groups.”

   Review

   Age-related changes in the immune system and challenges for the development of age-specific vaccines

   Annals of medicine·Mar 20, 2025

More on Immune response

1. Mrna COVID-19 vaccine increases SARS-CoV-2 neutralising antibodies in humans.

   “neutralising antibody responses were higher in Spikevax (Moderna) recipients, females, younger individuals and those with no underlying medical conditions”

   Humansafter two vaccine doses

   SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in Singapore

   medRxiv·May 30, 2022Preprint

More on SARS-CoV-2 neutralising antibodies

1. Mrna COVID-19 vaccine is associated with mortality in humans.

   “Furthermore, multiple doses correlated with increased mortality; each additional dose led to earlier deaths and prolonged periods of elevated mortality.”

   Humans

   Citizen volunteers' disclosure request and web database for post-vaccination deaths among 4 million mRNA COVID-19 vaccine recipients in Japan: A massive wave of deaths occurring months after vaccination, amplified and prolonged by frequent dosing

   Zenodo (CERN European Organization for Nuclear Research)·Feb 16, 2026Preprint